Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2020

Dec 2, 2020

29871_dirs_2020-12-02_f01aebc6-ff8c-4581-9e1b-1feddfd2b239.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2020-12-01

Reporting Person: Pietrowicz John W. (Sr MD Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-01 Common Stock Class A M 2500 $54.37 Acquired 44830 Direct
2020-12-01 Common Stock Class A S 2500 $180.0 Disposed 42330 Direct
2020-12-01 Common Stock Class A M 2500 $54.37 Acquired 44830 Direct
2020-12-01 Common Stock Class A S 2500 $180.0 Disposed 42330 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-01 Non-Qualified Stock Option (right to buy) $54.37 M 2500 Disposed 2021-09-15 Common Stock Class A (2500) Direct
2020-12-01 Non-Qualified Stock Option (right to buy) $54.37 M 2500 Disposed 2021-09-15 Common Stock Class A (2500) Direct

Footnotes

F1: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

F2: As of 9/15/2015, this option vested with respect to 100% of the granted number of shares covered by the option.